Latest filing published 13 Apr 2026 for Cloudbreak Pharma Inc. - B.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Yang Rong: trading record in brief
This profile gathers the share dealings of Yang Rong across 2 companies, led by Natures Sunshine Products Inc and Cloudbreak Pharma Inc. - B. We count 5 filings; the first trade dates from 1 June 2022 and the latest from 1 April 2026.
No open-market purchase appears, only 1 sale. The amount is not disclosed for 1 filing. Other entries cover 4 share grants. So far in 2026, the count stands at no purchases and 1 sale.
On 13 April 2026 came the latest disclosure, an open-market sale in Cloudbreak Pharma Inc. - B. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Yang Rong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 905,826 sharesShareXHKGHKEX:DA20260410E00758
- 8,000 shares0Common SharesSEC:0001628280-25-022628:0
- 5,236 shares@ US$19.10100.0% of flowCommon SharesSEC:0001628280-24-021518:0
- 9,355 shares0Common SharesSEC:0001628280-23-015620:0
- 7,658 shares0Common SharesSEC:0001934490-22-000002:0
5 of 5 declarations
